The FINDRISC questionnaire effectively discriminated diabetes, hypertension, and comorbidity in a cohort of 441 women, among whom 4.8% had type 2 diabetes and 14.3% had arterial hypertension.
Cross-Sectional (n=441)
No
Does the FINDRISC questionnaire predict diabetes mellitus II, arterial hypertension, and comorbidity in women from low-and-middle-income countries?
The FINDRISC questionnaire is an effective non-invasive tool for the early detection of diabetes, hypertension, and comorbidity in women from low-and-middle-income countries.
The Finnish Diabetes Risk Score (FINDRISC) has been implemented to assess diabetes risk. The authors aimed in this study to determine the prediction capacity of FINDRISC for the early detection of cardiovascular diseases in women. A prevalence study was carried out on 441 women of Pueblo Libre (Peru). Anthropometric variables, blood pressure, blood glucose and comorbidity were measured and entered in FINDRISC. 4.8% of the studied women suffered from DM2, 14.3% from AHT, 33% obesity and 8.6% comorbidity. We found that FINDRISC was the best method to discriminate DM, AHT and comorbidity. FINDRISC is an effective non-invasive tool for women from low-and-middle-income countries.
Rodríguez et al. (Wed,) conducted a cross-sectional in Diabetes mellitus and cardiovascular disease risk (n=441). FINDRISC questionnaire was evaluated on Discrimination of diabetes mellitus, arterial hypertension, and comorbidity. The FINDRISC questionnaire effectively discriminated diabetes, hypertension, and comorbidity in a cohort of 441 women, among whom 4.8% had type 2 diabetes and 14.3% had arterial hypertension.